Speaker illustration

Mr Bernt Kartman

AstraZeneca, Gothenburg (Sweden)

Hospitalisation for heart failure: short term cost savings associated with outcomes reported from the DECLARE-TIMI 58 trial

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

The economic burden of heart failure: findings from a systematic literature review

Event: Heart Failure 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Health-related quality of life in heart failure: findings from a systematic literature review

Event: Heart Failure 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb